BioClinica Inc
. said it agreed to sell itself for about $123 million to
JLL Partners
, which will merge the provider of clinical trial management services with
CoreLab Partners
Inc., a medical-imaging company that the firm also is acquiring.
JLL agreed to launch a
$7.25-a-share tender offer for the Newtown, Pa., company, a 20% premium
to Tuesday's 4 p.m. per-share trading price. The stock has climbed 18%
in the past 12 months....
No comments:
Post a Comment